Literature DB >> 16228000

Mutations in SECISBP2 result in abnormal thyroid hormone metabolism.

Alexandra M Dumitrescu1, Xiao-Hui Liao, Mohamed S Y Abdullah, Joaquin Lado-Abeal, Fathia Abdul Majed, Lars C Moeller, Gerard Boran, Lutz Schomburg, Roy E Weiss, Samuel Refetoff.   

Abstract

Incorporation of selenocysteine (Sec), through recoding of the UGA stop codon, creates a unique class of proteins. Mice lacking tRNA(Sec) die in utero, but the in vivo role of other components involved in selenoprotein synthesis is unknown, and Sec incorporation defects have not been described in humans. Deiodinases (DIOs) are selenoproteins involved in thyroid hormone metabolism. We identified three of seven siblings with clinical evidence of abnormal thyroid hormone metabolism. Their fibroblasts showed decreased DIO2 enzymatic activity not linked to the DIO2 locus. Systematic linkage analysis of genes involved in DIO2 synthesis and degradation led to the identification of an inherited Sec incorporation defect, caused by a homozygous missense mutation in SECISBP2 (also called SBP2). An unrelated child with a similar phenotype was compound heterozygous with respect to mutations in SECISBP2. Because SBP2 is epistatic to selenoprotein synthesis, these defects had a generalized effect on selenoproteins. Incomplete loss of SBP2 function probably causes the mild phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16228000     DOI: 10.1038/ng1654

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  122 in total

Review 1.  Inherited defects of thyroid hormone metabolism.

Authors:  A M Dumitrescu; S Refetoff
Journal:  Ann Endocrinol (Paris)       Date:  2011-04-21       Impact factor: 2.478

2.  [Synthesis, metabolism and diagnostics of thyroid hormones].

Authors:  J Köhrle; G Brabant
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

3.  Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gating.

Authors:  M W Pitts; A V Raman; A C Hashimoto; C Todorovic; R A Nichols; M J Berry
Journal:  Neuroscience       Date:  2012-02-21       Impact factor: 3.590

Review 4.  Role and Mechanisms of Actions of Thyroid Hormone on the Skeletal Development.

Authors:  Ha-Young Kim; Subburaman Mohan
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 5.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

6.  Role of type 2 deiodinase in response to acute lung injury (ALI) in mice.

Authors:  Olga Barca-Mayo; Xiao-Hui Liao; Caterina DiCosmo; Alexandra Dumitrescu; Liliana Moreno-Vinasco; Michael S Wade; Saad Sammani; Tamara Mirzapoiazova; Joe G N Garcia; Samuel Refetoff; Roy E Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 7.  Selenoproteins and their impact on human health through diverse physiological pathways.

Authors:  Behzad Moghadaszadeh; Alan H Beggs
Journal:  Physiology (Bethesda)       Date:  2006-10

8.  Distinct roles of deiodinases on the phenotype of Mct8 defect: a comparison of eight different mouse genotypes.

Authors:  Xiao-Hui Liao; Caterina Di Cosmo; Alexandra M Dumitrescu; Arturo Hernandez; Jacqueline Van Sande; Donald L St Germain; Roy E Weiss; Valerie Anne Galton; Samuel Refetoff
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

9.  Nuclear assembly of UGA decoding complexes on selenoprotein mRNAs: a mechanism for eluding nonsense-mediated decay?

Authors:  Lucia A de Jesus; Peter R Hoffmann; Tanya Michaud; Erin P Forry; Andrea Small-Howard; Robert J Stillwell; Nadya Morozova; John W Harney; Marla J Berry
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

10.  Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X).

Authors:  Caterina Di Cosmo; Neil McLellan; Xiao-Hui Liao; Kum Kum Khanna; Roy E Weiss; Laura Papp; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.